BioSpace News Archive

Biotech Bay

NuGEN Announces Launch of a New Streamlined Library Preparation Kit - Celero DNA-Seq

Today NuGEN Technologies announces a breakthrough DNA-Seq library system giving researchers a simplified library preparation system for Illumina sequencers.

February 8, 2018

·

2 min read

Business

GlycoMimetics Enters into Agreement with HOVON to Initiate Study Startup Activities for Planned Clinical Trial of GMI-1271 and Decitabine in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Who Are Unfit for Chemotherapy

GlycoMimetics, Inc. announced today that it has entered into an agreement with the Haemato Oncology Foundation for Adults in the Netherlands (HOVON) group to initiate clinical trial startup activities.

February 8, 2018

·

6 min read

Lone Star Bio

Moleculin Announces Activity with Pancreatic Cancer Drug

Moleculin Biotech with The University of Texas System on behalf of the MD Anderson Cancer Center today announced it has been able to show promising tumor suppression activity with its inhibitor of glycolysis, WP1122.

February 8, 2018

·

3 min read

Business

Emergent BioSolutions to Release Fourth Quarter and Full Year 2017 Financial Results and Conduct a Conference Call on February 22, 2018

This conference call can be accessed live by telephone or by webcast.

February 8, 2018

·

1 min read

BioCapital

Pii and its Partners Received FDA Market Approval for Seven Products and Commercially Launched 6 Products in 2017

In early 2017, Pii conducted a cGMP baseline risk assessment and implemented remediation initiatives to enhance its cGMP systems.

February 8, 2018

·

1 min read

Business

Agilent to Support Korea Doping Control Center

Agilent today announced it will collaborate with the Doping Control Center in Seoul, South Korea, to ensure that athletes from around the world are quickly and accurately tested to determine whether any have been using banned substances to enhance their performanc

February 8, 2018

·

2 min read

FDA

U.S. FDA Approves NorthStar Medical Radioisotopes’ RadioGenix System (Technetium Tc 99m Generator) for Non-uranium Sourced Molybdenum-99 (Mo-99) Production of Imaging Isotope Technetium-99m (Tc-99m)

NorthStar Medical Radioisotopes today announced that the FDA has approved the RadioGenix System, an innovative, high tech radioisotope separation platform indicated for use in producing the widely used medical radioisotope technetium-99 (Tc-99m) from NorthStar’s non-uranium based molybdenum-99 (Mo-99).

February 8, 2018

·

8 min read

Drug Development

Herantis Pharma Completes Patient Enrolment in Phase I Study of Lymfactin Gene Therapy for Secondary Lymphedema and Has Submitted Phase II Application

The company intends to proceed rapidly to a randomized, placebo-controlled Phase 2 study of Lymfactin in the same indication and has already submitted the clinical trial application to the regulatory authorities.

February 8, 2018

·

3 min read

Business

Opiant Pharmaceuticals to Record Approximately $11.7M in Royalty and Milestone Payments Related to 2017 Sales of NARCAN Nasal Spray for Opioid Overdose

Opiant’s actual financial results for the five-month period ended December 31, 2017, will be reported in the Transition Report on Form 10-KT, to be filed in March 2018.

February 8, 2018

·

3 min read

Drug Development

Innovation Pharmaceuticals Concludes Successful Phase IIa Trial of Kevetrin for Ovarian Cancer; Intra-Tumor Modulation of p53 Observed

The Company initiated the trial for the purpose of demonstrating modulation of the key tumor-suppressor protein p53, which was achieved in analysis of the first patients at the lowest dose of Kevetrin.

February 8, 2018

·

7 min read